Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.57 USD | -0.48% | 0.00% | -56.29% |
Jun. 04 | Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing | MT |
May. 31 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-56.29% | 1.79B | |
+18.89% | 125B | |
+13.74% | 108B | |
-7.48% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-14.09% | 16.37B | |
+1.68% | 13.58B | |
+27.67% | 11.66B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx, Inc.
- JMP Securities Adjusts Price Target on Inhibrx to $35 From $40, Maintains Market Outperform Rating